Features & Analyses

Simon Leung, Partner of Baker McKenzie, and Terry Xu, Senior Counsel at FenXun Partners, examine key regulatory shifts in 2024 and provide an outlook of potential regulatory trends for the banking and finance sector in 2025

China Law & Practice Awards 2024 sees a broad spectrum of law firms seize crown in individual practices. Fangda Partners and Clifford Chance win top accolades in the 18th annual CLP Awards.

Casper Sek and Alan Zhang of Jingtian & Gongcheng provide answers to key questions on China’s data transfer regime, and identify some vital trends

In 2024, significant progress was made in the fields of legislation, merger control, administrative enforcement, and litigation under the PRC Anti-Monopoly Law. Huang Wei, Gao Chang, Zhu Fan and Ren Yuying of Tian Yuan Law Firm set out an overview of the major developments and key takeaways

Jianwei (Jerry) Fang, Chuchen (Julie) Hou and Jiaying (Kate) Jiang of Zhong Lun Law Firm discuss last year’s most significant legislative and judicial developments in civil and commercial dispute resolution in China

In 2024, the U.S. continued placing wide-ranging restrictions on Chinese interests. What made that year different was the impact those restrictions have on third countries. Charles Wu of Clyde & Co reviews the legislative changes, and offers practical insights into their potential impact with a focus on third countries, and the path forward in 2025

Dongping Liu and Xin Luo of Zhong Lun Law Firm analyze a significant set of new guidelines which are vital for foreign enterprises with a patent portfolio in China

While companies from third countries do not necessarily need to divest from China to invest in the U.S., they should be prepared for CFIUS scrutiny of their China operations

In Part I of this series, Daisy Duan, Yingjie Yang and Cuishi Li of King & Wood Mallesons introduced the implications of the amended PRC Company Law for Formal Capital Reductions. In Part II, the authors focus on the accounting and tax treatments of Substantive Capital Reductions, and analyze the tax risks of shareholders with regard to capital reductions not made at fair market value.